Member Info for fastduckharry

If the lockup ends tomorrow, it will mean that FTSE Russell will have adjust DARK for their indices because their weighting formula factors against lockup shares.
Will be an interesting day tomorrow, simply because we have had two secondary placings since the ipo. The evidence of these placings suggest that few shares were really sold. More a case of moving them into another holding vehicle. Which makes one wonder if the sought after outcome was to actually decrease the number of shares in lockup. Not only is tomorrow significant but also Tuesday 30 November, a national day for giving in the US also and I'm not joking, Computer Security Day. Why because am sure that the next Trading Update from DARK will be conveniently timed before this day, probably planned already.

Interesting days ahead, let's see how the cards are played, fascinating.
GLA (and I mean all).

If one takes a who benefits view, for the motivation of Peel Hunt's note. Then one can take the link of the Peel Hunt employees and start to consider the whole episode from a different perspective. For example consider if, Jefferies clients have more likely benefitted from the drop in Dark price more than Peel Hunt's. Not possible for Jefferies to issue a sell note but do they know someone who could?
How come that relative minnow Peel Hunt, has managed to do so much short term disruption to the share price? Does not make sense. In the same way that Jefferies issued a note for GAMA @1550p whereas Peel Hunt 2225p last month. Many possibilities there. Including GAMA want more staff to participate in shareholding. A lower entry price would be beneficial. Or is a potential takeover being planned?
Keep an open mind, I bought more DARK this week alongwith most of you, no doubt. Long term holders should be thanking Peel Hunt or whoever managed this week. Was selling GAMA, as price was too high, though 1550p would be too low, price has stuck slightly above 1800p so far. As a low not unreasonable, did the Jefferies teaperson issue the note? Of course not, there was a reason though, there always is.

Good luck to all long term holders - though I don't expect many of you to have got this far.

Jefferies have consistently been the most bullish analyst regarding Amazon stock. Their predictions have been derided by other market experts and commentators but Amazon are proving the doubters wrong time and time again. Reaching a US$1trn valuation as predicted. The prediction of $4,000 a share (when $2328) by 1923 is likely to come true as well, the stock already having been as high as $3773 (currently $3376)

This (below) is Monday's news, was in the Guardian also. Talk of using AI but no mention of DARK. Amazon have a working relationship with DARK, therefore it is hoped the AI will be DARK's. A poor show if not.
Maybe Charles or somebody else familiar in communication with DARK, could ask the question - are you involved?

Perhaps this week has been about softening up DARK prior to Amazon making a bid? Though they are unlikely to be alone in this respect. As Administration pressure is on in the US to come up with an AI cybersecurity system guaranteed to work.

https://www.theguardian.com/uk-news/2021/oct/26/amazon-web-services-aws-contract-data-mi5-mi6-gchq?mid=1
https://www.computing.co.uk/news/4039226/gchq-signs-deal-amazon-host-secret-material

https://www.darktrace.com/en/press/2019/294/

danrh, please be assured that I do have a basic grasp of what ONT can offer. However, in relation to everything else, the revenues generated by Covid must be mega when compared to everything else. That said the sliding sp suggests that the number crunchers have done their stuff and decided not mega enough. When it comes to the valuation of ONT a mathematician has more clout than a biochemist it would seem. Not that I'm trying to knock the share, my beef is about IPO share buyback. That said am certainly not wishing a highly transmissable lethal virus to emerge either, even if it was a boon to the ONT sp.

GLA

EOB, just need to be patient with finnCap. For the time being they are profitable and are paying a decent dividend. Owned ENET for a week, probably would be still holding but a regular lse poster seemed like an employee to me. therefore found hard to trust ITX are not one I would want to hold. Had Polb (spinoff from Open Orphan) for a few days then decided I didn't want to hold as medical stocks are close to gambling, like many commodity stocks. eEnergy looks interesting, will try and find time to listen to the recent investormeet event over the weekend. Am on the lookout for some more growth winners at the penny share level. That said don't want any commodity stocks. Payments companies are in a very competitive market need a lot of luck to find the right one. Though FNX are different with scope to multiply overseas, if they can reproduce UK success. As it is, they are profitable and paying a dividend, not to be scoffed at.

Nice find EOB, doesn't appear to be on the finnCap website yet. The buyer Access Group does appear to be a very good home for this business.
It seems as if finnCap have lost Ideagen (IDEA) rns today. Can't please everybody.
Had a look at Angle this morning, eating up a lot of money but signs are very promising. Apart from your interest, I notice that finnCap are involved with them.
Yes finnCap should trade higher, but at present levels, dividends reinvested should provide ample compensation longterm. My first reinvested dividend with GBG when they were pennies has to be worth now, as much as the original investment.

Latest numbers from the US highlight the worsening problem of ransomware attacks.

https://uk.finance.yahoo.com/news/590-mn-ransomware-payments-reported-163744200.html

Have a good weekend

Danrh, below from rns 15 June 2021. These shares issued @118.6p and qualified for the last dividend. Scrip divi shares from that did issue at 131.4p but only around 240k new. Most brokers offer dividend re-investment and there is the DRIP option for paper holders if IPO want investors to have the opportunity. Am happy just to know that IPO still have 10% of ONT. Am steering clear of covid related stocks now when it comes to my money. Good luck to you though.

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), the developer of intellectual property-based businesses, announces that further to the announcement made on 20 May 2021 in relation to the Scrip Dividend, the Group has received valid elections from shareholders resulting in a requirement to issue 434,380 new Ordinary Shares ("New Shares").

An application has been made for the New Shares to be issued in connection with the Scrip Dividend to be admitted to the premium segment of the Official List of the Financial Conduct Authority and to trading on the main market for listed securities of the London Stock Exchange respectively.

Admission of the New Shares is now expected to be effective on 17 June 2021, as opposed to 16 June 2021 as previously disclosed. Following admission and in accordance with the Disclosure and Transparency Rules of the Financial Conduct Authority, the Group will have 1,062,788,114 Ordinary Shares in issue, each share carrying the right to one vote. The Group does not hold any shares in Treasury.



The above figure of 1,062,788,114 Ordinary Shares may be used by shareholders in the Group as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Group under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

Danrh, with regard to ONT they have come out with a revenue record busting update today, therefore growth expansion could well support the sp. Therefore my forecast was hopelessly wrong, but happy to be so. Not going to argue with you regarding NAV as my main complaint is with regard to the scrip dividend. Do you think it makes sense?

The placing wasn't a surprise. The shares on offer have all been snapped up at a significant 630p (another plus for finnCap). That reflects the strong institutional interest in the company. They just weren't prepared to push the price up too high in a scramble for shares at this stage. If the last placing is a guide, it should place a floor for the sp @630p (barring a global market correction). At least until we get more news from the company.

Last year Elixirr issued a Trading Update on October 19. Can't be certain that we will get one so soon this year, but would expect something by mid-November at the latest.

I have no confidence. Why issue scrip dividend shares and then buy back a few months later at an overall loss? This is before, factoring in the recent dividend payment for the special dividend shares issued in June, the cost of administrating the Scrip dividend scheme and also the administrative costs of the share buy back. To make it clear, am waiting for news that confirms the ending of the Scrip Dividend scheme.

Would also would like to see the entry price for buy back lowered, so that purchases are only made at times when we get a genuine market correction. Using NAV as a guide is all well and good but the current Oxford Nanopore contribution to that figure is not secure. Thought the opening market price too high and would not be surprised if further falls lead to 450p a share. In other words use the float price of ONT to determine "buy back NAV". Afterall that was the price that delivered this buy back cash.

Share buy back presumably to reduce the number of shares in circulation. Which should have a positively marginal impact on the sp and future dividends payable. Approximately 680k new shares have been issued as a result of 2 scrip dividends this year. Does this make sense? I have my dividends on automatic reinvestment for little cost and at no extra cost to IP Group.

https://www.finncapcavendish.com/deals/sentenial-nuapay-eml-payments/

https://www.finncapcavendish.com/deals/qdime-cortland/

Hi Allenby,

many thanks for going to the trouble of providing the details of the major shareholders in Gamma. I apologise for not wording my post clear enough. If a bid for GAMA were to emerge, it would be interesting to look over the major holdings list of the company, if public, which is actually making that bid.
This is all because Jefferies issued a hold note with an outlier target price of 1550p,( a reversal of a year of 20% plus growth, by going back to Sept 20 sp levels). They may know something that Barclays and Peel Hunt don't know. If there is a problem, shareholders should be told.

FY Revenues guidance of £47-50m looks cautious. £47m would mean lower H2 revenues than H1. Last year H2 revenues were 23% up on H1. Factor in the performance of the new partners and a full half of numbers from the current House of Brands and for me £50m would be a minor disappointment. Too early to worry, nothing like a numberless above market or a forecast upper range of expectations trading update, to boost sentiment. Still leaving a little room to surprise with the final results.

Just a quickie. Busy last night and missed the late Holdings in Company rns. The answer to my question of who was buying the shares, was already out there; BlackRock. Should a bid emerge for Gamma will be curious to find out, who the major shareholders of the company involved are.

I agree with sledgey121. The price had gone crazy. Don't usually trade but selling in response Jefferies 1550p target hold note, was the fourth time had sold all my GAMA since mid July. Back in now. Am suspicious of the motivation for the note. That makes me suspicious of the move over 2300p. The obvious logical guess is that GAMA are being softened up for a takeover bid by a US telecommunications company and Jefferies are involved somehow. Would give that company a solid foothold both in the UK and the EU. It could well be that company are also coveting Gamma's software, which might augment their operations in the US.

As for Gamma am sure that H2 will be better than H1 including in Europe, therefore either way will not be tempted to sell again below 2100p even if drops to 1550p though unlikely, would be buying more. Have noticed some solid after hours buying at current levels. Am wondering by whom. Recent history suggests that Gamma will not issue a trading update until January. If all is well, perhaps their advisors might feel it is prudent to issue one, by the end of next month, just to reassure the market.

If the sp collapses again tomorrow, I promise to avoid posting on here again, don't worry about that. Won't change my opinion unless the evidence suggests I'm wrong.

GLA (don't weaken)

Hi Stocky

You are welcome to express your own opinion, am I going to be upset if your dreams come true? No way.

The good news is that serious illness and deaths have stalled. Most of the problems that CPC face, however, have not changed. Driver shortages are causing problems with food supplies in hospitality and forecast to get worse. Staffing problems are not improving. CEO Clive Watson has called for a 2-3 year visa to allow staff to come to the UK to work in hospitality. Even Tim Martin of Wetherspoons has backed him up. Booster shots have to be given at least 6 months after the second vaccination, meaning some over 50s might not get theirs before Christmas.
CPC have good management, they will cope the best they can. I'll stick with my 130p+ target until the January Trading Update. Not much downside risk from current levels in any case, therefore no worry, will be holding onto my shares. 200p+ will come eventually. Will have topped up before then,( I hope).

In the meantime this is the previous management's website for the new acquisition.

https://www.cliftonvillehotel.co.uk

It has a good reputation for locally caught fish on the menus. The menu hasn't been changed the last few days, hopefully that is a sign of a staffing problem.

30 bedrooms, apparently each has a sea view of sorts

Incidentally the hotel was on offer at £1.8m, therefore, CPC managed to get £100k off the price.

GLA

With regard to shares doubling in price. I noticed yesterday that SED managed to do that in just over 2 months. I think they have more chance of doubling again in your 6-8 month timeframe. Take a look.

Went through the highlights of the year and the numbers, including a slide showing the growth of business from a now major client, over the last two years. Emphasizing how important it is to get the smaller (trial) initial order from the Tier 1 institution. Not to over-promise and fail to deliver, in order to get an expanded contract, they will come.

Most significant is that Beeks' Proximity Cloud service is unique. Major Tier 1 Financial companies are prevented from using the usual cloud systems, for their core activities, due to security requirements. That's because the companies providing the service would technically have access to the data. Proximity Cloud circumvents that problem as the cloud infrastructure will be all in house (of the financial institution). This brings all ofthe top Tier 1 financial institutions into play.

Other snippets of info gleaned include:

Gordon McArthur says that Proximity Cloud has attracted a lot of interest already. The company focus is going to be developing the product leading to Proximity 2, Proximity 3 (etc).

Beeks are hoping that Proximity will generate revenues many multiples higher than present. Extra staff hiring likely to be around 25 over the year.

He did say that next year's profit would be at this year's level due to the higher capex required to install Proximity.

On being asked what Beeks total market is, Gordon McArthur says we don't know. He goes on to say that the top 30 Tier 1 institutions each spend $100-150m on services relevant to Beeks annually.
Towards the end of the session, a questioner asks what the likely revenues would be in three years time. Gordon McArthur said I can't tell you that. We have a number but I can't tell you.
......

Last week I calculated that Beeks would hit £10 a share within 8-10 years. Now my instincts tell me that the Beeks sp will reach this mark within 5 years. Just think of the expenditure of the top Tier 1 financial institutions. The company is aiming to capitalize on their market leading advantage with Proximity Cloud, which has been developed over the last 18 months. Nothing to suggest that Gordon McArthur and Beeks will be doing anything else, having heard the year ahead being described as landmark and breakthrough.

Of course success over the next few years is likely to attract the attentions of a predator. That is just another reason to be holding BKS.